Anchor Therapeutics Obtains $10,000,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f2f806cd-6102-4495-b69d-96766eca0b9b&Preview=1 - Date
8/20/2010 - Company Name
Anchor Therapeutics - Mailing Address
67 Rogers St. Cambridge, MA 02142 - Company Description
Anchor Therapeutics is developing first-in-class pepducin drug candidates, novel molecules that can selectively target G protein coupled receptors (GPCRs) to allosterically modulate GPCR signaling. - Website
http://www.anchortx.com - Transaction Type
Venture Equity - Transaction Amount
$10,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
TVM Capital - Venture Investor
HealthCare Ventures - Venture Investor
Novartis BioVenture Fund
